145 related articles for article (PubMed ID: 27209699)
1. Inhibition of dual-specificity phosphatase 26 by ethyl-3,4-dephostatin: Ethyl-3,4-dephostatin as a multiphosphatase inhibitor.
Seo H; Cho S
Pharmazie; 2016 Apr; 71(4):196-200. PubMed ID: 27209699
[TBL] [Abstract][Full Text] [Related]
2. NSC-87877, inhibitor of SHP-1/2 PTPs, inhibits dual-specificity phosphatase 26 (DUSP26).
Song M; Park JE; Park SG; Lee DH; Choi HK; Park BC; Ryu SE; Kim JH; Cho S
Biochem Biophys Res Commun; 2009 Apr; 381(4):491-5. PubMed ID: 19233143
[TBL] [Abstract][Full Text] [Related]
3. NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.
Shi Y; Ma IT; Patel RH; Shang X; Chen Z; Zhao Y; Cheng J; Fan Y; Rojas Y; Barbieri E; Chen Z; Yu Y; Jin J; Kim ES; Shohet JM; Vasudevan SA; Yang J
Cell Death Dis; 2015 Aug; 6(8):e1841. PubMed ID: 26247726
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel dual-specificity phosphatase 26 inhibitors by a hybrid virtual screening approach based on pharmacophore and molecular docking.
Ren JX; Cheng Z; Huang YX; Zhao JF; Guo P; Zou ZM; Xie Y
Biomed Pharmacother; 2017 May; 89():376-385. PubMed ID: 28249240
[TBL] [Abstract][Full Text] [Related]
5. PTP inhibitor IV protects JNK kinase activity by inhibiting dual-specificity phosphatase 14 (DUSP14).
Park JE; Park BC; Song M; Park SG; Lee DH; Park SY; Kim JH; Cho S
Biochem Biophys Res Commun; 2009 Oct; 387(4):795-9. PubMed ID: 19646420
[TBL] [Abstract][Full Text] [Related]
6. DUSP26 negatively affects the proliferation of epithelial cells, an effect not mediated by dephosphorylation of MAPKs.
Patterson KI; Brummer T; Daly RJ; O'Brien PM
Biochim Biophys Acta; 2010 Sep; 1803(9):1003-12. PubMed ID: 20347885
[TBL] [Abstract][Full Text] [Related]
7. High-resolution crystal structure of the catalytic domain of human dual-specificity phosphatase 26.
Won EY; Xie Y; Takemoto C; Chen L; Liu ZJ; Wang BC; Lee D; Woo EJ; Park SG; Shirouzu M; Yokoyama S; Kim SJ; Chi SW
Acta Crystallogr D Biol Crystallogr; 2013 Jun; 69(Pt 6):1160-70. PubMed ID: 23695260
[TBL] [Abstract][Full Text] [Related]
8. Atomic structure of dual-specificity phosphatase 26, a novel p53 phosphatase.
Lokareddy RK; Bhardwaj A; Cingolani G
Biochemistry; 2013 Feb; 52(5):938-48. PubMed ID: 23298255
[TBL] [Abstract][Full Text] [Related]
9. Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma.
Shang X; Vasudevan SA; Yu Y; Ge N; Ludwig AD; Wesson CL; Wang K; Burlingame SM; Zhao YJ; Rao PH; Lu X; Russell HV; Okcu MF; Hicks MJ; Shohet JM; Donehower LA; Nuchtern JG; Yang J
Oncogene; 2010 Sep; 29(35):4938-46. PubMed ID: 20562916
[TBL] [Abstract][Full Text] [Related]
10. A novel amplification target, DUSP26, promotes anaplastic thyroid cancer cell growth by inhibiting p38 MAPK activity.
Yu W; Imoto I; Inoue J; Onda M; Emi M; Inazawa J
Oncogene; 2007 Feb; 26(8):1178-87. PubMed ID: 16924234
[TBL] [Abstract][Full Text] [Related]
11. Structural Insight into the Critical Role of the N-Terminal Region in the Catalytic Activity of Dual-Specificity Phosphatase 26.
Won EY; Lee SO; Lee DH; Lee D; Bae KH; Lee SC; Kim SJ; Chi SW
PLoS One; 2016; 11(9):e0162115. PubMed ID: 27583453
[TBL] [Abstract][Full Text] [Related]
12. Dual-specificity phosphatase 26 protects against kidney injury caused by ischaemia-reperfusion through restraint of TAK1-JNK/p38-mediated apoptosis and inflammation of renal tubular epithelial cells.
Xiang H; Li Z; Li Y; Zheng J; Dou M; Xue W; Wu X
Toxicol Appl Pharmacol; 2024 Jun; 487():116954. PubMed ID: 38705402
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ATRA-induced myeloid differentiation in acute promyelocytic leukemia by a new protein tyrosine phosphatase inhibitor, 3,4-dephostatin.
Uesugi Y; Fuse I; Toba K; Kishi K; Hashimoto S; Furukawa T; Narita M; Takahashi M; Aizawa Y
J Exp Clin Cancer Res; 2000 Sep; 19(3):363-6. PubMed ID: 11144530
[TBL] [Abstract][Full Text] [Related]
14. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
Wadgaonkar R; Pierce JW; Somnay K; Damico RL; Crow MT; Collins T; Garcia JG
Am J Respir Cell Mol Biol; 2004 Oct; 31(4):423-31. PubMed ID: 15231489
[TBL] [Abstract][Full Text] [Related]
15. Ginkgolic acid as a dual-targeting inhibitor for protein tyrosine phosphatases relevant to insulin resistance.
Yoon SY; Lee JH; Kwon SJ; Kang HJ; Chung SJ
Bioorg Chem; 2018 Dec; 81():264-269. PubMed ID: 30153591
[TBL] [Abstract][Full Text] [Related]
16. A Review of DUSP26: Structure, Regulation and Relevance in Human Disease.
Thompson EM; Stoker AW
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466673
[TBL] [Abstract][Full Text] [Related]
17. A novel site on dual-specificity phosphatase MKP7/DUSP16 is required for catalysis and MAPK binding.
Shillingford S; Zhang L; Surovtseva Y; Dorry S; Lolis E; Bennett AM
J Biol Chem; 2022 Dec; 298(12):102617. PubMed ID: 36272649
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of a Src homology 2 domain containing protein tyrosine phosphatase by vanadate in the primary culture of hepatocytes.
Pugazhenthi S; Tanha F; Dahl B; Khandelwal RL
Arch Biochem Biophys; 1996 Nov; 335(2):273-82. PubMed ID: 8914924
[TBL] [Abstract][Full Text] [Related]
19. Polycyclic aromatic hydrocarbon (PAH)-mediated upregulation of hepatic microRNA-181 family promotes cancer cell migration by targeting MAPK phosphatase-5, regulating the activation of p38 MAPK.
Song MK; Park YK; Ryu JC
Toxicol Appl Pharmacol; 2013 Nov; 273(1):130-9. PubMed ID: 23993976
[TBL] [Abstract][Full Text] [Related]
20. Dual-specificity phosphatase 26-dificient neurons are susceptible to oxygen-glucose deprivation/reoxygenation-evoked apoptosis and proinflammatory response by affecting the TAK1-medaited JNK/P38 MAPK pathway.
Zhao H; Lv J; Meng L; Lv J; Li Z
Int Immunopharmacol; 2023 Apr; 117():109980. PubMed ID: 37012870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]